Fracture risk assessment in chronic kidney disease, prospective testing under real world environments (FRACTURE): A prospective study

BMC Nephrology

Volumn 11, Issue 1, 2010, Pages

  West, Sarah L ^a,b   Lok, Charmaine E ^b   Jamal, Sophie A ^a,b  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TETRACYCLINE;

ADULT; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE TURNOVER; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HIP; HUMAN; MALE; MORPHOMETRICS; MUSCLE STRENGTH; OSSIFICATION; PROSPECTIVE STUDY; RADIUS; RISK ASSESSMENT; SELF REPORT; SPINE FRACTURE; TIBIA; AGED; BIOPSY; BONE; CANADA; CHEMISTRY; CHRONIC DISEASE; DISEASE COURSE; FALLING; FOLLOW UP; KIDNEY DISEASE; METABOLIC BONE DISEASE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHOTON ABSORPTIOMETRY; RADIOGRAPHY; RENAL OSTEODYSTROPHY; STATISTICS;

ABSORPTIOMETRY, PHOTON; ACCIDENTAL FALLS; ADULT; AGED; BIOPSY; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MUSCLE STRENGTH; ONTARIO; PROSPECTIVE STUDIES; RENAL OSTEODYSTROPHY; RESEARCH DESIGN; RISK ASSESSMENT; SPINAL FRACTURES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77955673972     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-11-17     Document Type: Article

References (32)

1. The burden of kidney disease: improving global outcomes. G Eknoyan N Lameire R Barsoum KU Eckardt A Levin N Levin F Locatelli A MacLeod R Vanholder R Walker H Wang, Kidney Int 2004 66 4 1310 1314 10.1111/j.1523-1755.2004.00894.x 15458424
2. Cortical pQCT measures are associated with fractures in dialysis patients. SA Jamal J Gilbert C Gordon DC Bauer, J Bone Miner Res 2006 21 4 543 548 10.1359/jbmr.060105 16598374
3. Impaired muscle strength is associated with fractures in hemodialysis patients. SA Jamal RE Leiter V Jassal CJ Hamilton DC Bauer, Osteoporos Int 2006 17 9 1390 1397 10.1007/s00198-006-0133-y 16799753
4. Renal osteodystrophy. HH Malluche MC Faugere, N Engl J Med 1989 321 5 317 319 10.1056/NEJM198908033210509 2747771
5. Osteoporosis in end-state renal disease. JS Lindberg SM Moe, Semin Nephrol 1999 19 2 115 122 10192243
6. Epidemiology of osteoporosis and osteoporotic fractures. SR Cummings JL Kelsey MC Nevitt KJ O'Dowd, Epidemiol Rev 1985 7 178 208 3902494
7. Risk factors for vertebral fractures in renal osteodystrophy. K Atsumi K Kushida K Yamazaki S Shimizu A Ohmura T Inoue, Am J Kidney Dis 1999 33 2 287 293 10.1016/S0272-6386(99)70302-1 10023640
8. Dialysis osteodystrophy. A study involving 94 patients. YL Chan TJ Furlong CJ Cornish S Posen, Medicine (Baltimore) 1985 64 5 296 309 3839891
9. Femoral neck fractures in patients receiving long-term dialysis. PC Schaab G Murphy AH Tzamaloukas MB Hays TL Merlin B Eisenberg PS Avasthi RV Worrell, Clin Orthop Relat Res 1990 260 224 231 2225628
10. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. EF Vonesh J Moran, J Am Soc Nephrol 1999 10 2 354 365 10215336
11. Cardiovascular mortality and morbidity in dialysis patients. G Eknoyan, Miner Electrolyte Metab 1999 25 1-2 100 104 10.1159/000057429 10207269
12. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. M Coco H Rush, Am J Kidney Dis 2000 36 6 1115 1121 10.1053/ajkd.2000.19812 11096034
13. Fracture and bone mineral density in hemodialysis patients. MA Fontaine A Albert B Dubois A Saint-Remy G Rorive, Clin Nephrol 2000 54 3 218 226 11020020
14. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. National Kidney Foundation, Am J Kidney Dis 2002 39 2 Suppl 1 1 266 11904577
15. Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus. M Inaba S Okuno Y Kumeda T Yamakawa E Ishimura Y Nishizawa, Calcif Tissue Int 2005 76 4 256 260 10.1007/s00223-004- 0094-0 15692725
16. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. P Urena O Bernard-Poenaru A Ostertag C Baudoin M Cohen-Solal T Cantor MC de Vernejoul, Nephrol Dial Transplant 2003 18 11 2325 2331 10.1093/ndt/gfg403 14551361
17. Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. T Yamaguchi E Kanno J Tsubota T Shiomi M Nakai S Hattori, Bone 1996 19 5 549 555 10.1016/S8756-3282(96)00246-3 8922656
18. Risk factors for hip fracture in hemodialysis patients. H Kaji M Suzuki S Yano T Sugimoto K Chihara S Hattori K Sekita, Am J Nephrol 2002 22 4 325 331 10.1159/000065222 12169863
19. Update on renal osteodystrophy: pathogenesis and clinical management. K Sakhaee GB Gonzalez, Am J Med Sci 1999 317 4 251 260 10.1097/00000441-199904000- 00008 10210362
20. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. S Boutroy ML Bouxsein F Munoz PD Delmas, J Clin Endocrinol Metab 2005 90 12 6508 6515 10.1210/jc.2005-1258 16189253
21. Endocrine Influences on bone cells and bone remodeling evaluated by clinical histomorphometry. P Meunier C Bressot, Anonymous New York: Raven Press 1983 455
22. The accuracy of self-report of fractures in elderly women: evidence from a prospective study. MC Nevitt SR Cummings WS Browner DG Seeley JA Cauley TM Vogt DM Black, Am J Epidemiol 1992 135 5 490 499 1570815
23. Defining incident vertebral deformity: a prospective comparison of several approaches. The Study of Osteoporotic Fractures Research Group. DM Black L Palermo MC Nevitt HK Genant L Christensen SR Cummings, J Bone Miner Res 1999 14 1 90 101 10.1359/jbmr.1999.14.1.90 9893070
24. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. JD Adachi G Loannidis C Berger L Joseph A Papaioannou L Pickard EA Papadimitropoulos W Hopman S Poliquin JC Prior DA Hanley WP Olszynski T Anastassiades JP Brown T Murray SA Jackson A Tenenhouse Canadian Multicentre Osteoporosis Study (CaMos) Research Group, Osteoporos Int 2001 12 11 903 908 10.1007/s001980170017 11804016
25. Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group. SR Cummings L Palermo W Browner R Marcus R Wallace J Pearson T Blackwell S Eckert D Black, JAMA 2000 283 10 1318 1321 10.1001/jama.283.10.1318 10714731
26. Clinical use of bone densitometry: scientific review. SR Cummings D Bates DM Black, JAMA 2002 288 15 1889 1897 10.1001/jama.288.15.1889 12377088 (Pubitemid 35168145)
27. Clinical use of bone densitometry: clinical applications. DW Bates DM Black SR Cummings, JAMA 2002 288 15 1898 1900 10.1001/jama.288.15.1898 12377089
28. Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. SR Cummings D Black, Am J Med 1995 98 2A 24S 28S 10.1016/S0002-9343(05)80041-5 7709929
29. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. SR Cummings DM Black DE Thompson WB Applegate E Barrett-Connor TA Musliner L Palermo R Prineas SM Rubin JC Scott T Vogt R Wallace AJ Yates AZ LaCroix, JAMA 1998 280 24 2077 2082 10.1001/jama.280.24.2077 9875874
30. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. DM Black SL Greenspan KE Ensrud L Palermo JA McGowan TF Lang P Garnero ML Bouxsein JP Bilezikian CJ Rosen PaTH Study Investigators, N Engl J Med 2003 349 13 1207 1215 10.1056/NEJMoa031975 14500804
31. Design of the Fracture Intervention Trial. DM Black TF Reiss MC Nevitt J Cauley D Karpf SR Cummings, Osteoporos Int 1993 3 Suppl 3 29 39 10.1007/BF01623005 8298200
32. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. B Ettinger DM Black BH Mitlak RK Knickerbocker T Nickelsen HK Genant C Christiansen PD Delmas JR Zanchetta J Stakkestad CC Gluer K Krueger FJ Cohen S Eckert KE Ensrud LV Avioli P Lips SR Cummings, JAMA 1999 282 7 637 645 10.1001/jama.282.7.637 10517716